Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.David Wisniewski, Bayard D. Clarkson, Darren R. Veach et al.|PubMed|2002Cited by 161
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growthDavid Wisniewski, Stanley Lipkowitz|Journal of Biological Chemistry|2022Cited by 7
EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibitionDavid Wisniewski, Stanley Lipkowitz|Oncogene|2025Cited by 1
Symposium: Making Open Science a RealityFrederick Verbruggen, Andy J. Wills, Tony Ross‐Hellauer et al.|OSF Preprints (OSF Preprints)|2019Cited by 0